Evaluation and treatment of male and female pattern hair loss
Authors
Abstract:
This article doesn't have abstract
similar resources
Finasteride treatment of female pattern hair loss.
OBJECTIVE To evaluate the efficacy of oral finasteride therapy associated with an oral contraceptive containing drospirenone and ethinyl estradiol in premenopausal women with female pattern hair loss. SETTING Outpatient consultation for hair disorders at the Department of Dermatology, University of Bologna. PATIENTS AND INTERVENTION Thirty-seven women with female pattern hair loss were trea...
full textMedical treatments for male and female pattern hair loss.
UNLABELLED Male and female pattern hair loss affects a large percentage of the population, and patients frequently present for treatment of this to their dermatologist. Here we review the many treatments available for hair loss. We review the evidence for each, and outline the most effective treatment strategies for both men and women. LEARNING OBJECTIVE At the conclusion of this article, the...
full textFemale pattern hair loss: Current treatment concepts
Fewer than 45% of women go through life with a full head of hair. Female pattern hair loss is the commonest cause of hair loss in women and prevalence increases with advancing age. Affected women may experience psychological distress and impaired social functioning. In most cases the diagnosis can be made clinically and the condition treated medically. While many women using oral antiandrogens ...
full textFemale Pattern Hair Loss
CONTEXT Female pattern hair loss (FPHL) also known as female androgenetic alopecia is a common condition afflicting millions of women that can be cosmetically disrupting. Prompt diagnosis and treatment are essential for obtaining optimal outcome. This review addresses the clinical presentation of female pattern hair loss, its differential diagnosis and treatment modalities. EVIDENCE ACQUISITI...
full textfemale pattern hair loss
results: the most important diseases to consider in the differential diagnosis of fphl include chronic telogen effluvium (cte), permanent alopecia after chemotherapy (pac), alopecia areata incognito (aai) and frontal fibrosing alopecia (ffa). this review describes criteria for distinguishing these conditions from fphl. conclusions: the only approved treatment for fphl, which is 2% topical minox...
full textMy Resources
Journal title
volume 8 issue 2
pages 32- 46
publication date 2005-01-01
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023